TNON insider transaction filings
Tenon Medical, Inc. — 40 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-11. Screen TNON transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 14 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 9 legs across 4 filings by 1 insider — 129,945 shares, $500,223 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 9 legs across 5 filings by 1 insider — 136,599 shares, $605,668 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 65,582 shares @ $5.56 ($364,636) by HRT FINANCIAL LP, filed 2026-09-11.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| HRT FINANCIAL LP — 10% owner | 5 | 9 legs · 129,945 sh · $500,223 | 9 legs · 136,599 sh · $605,668 | — |
| Williamson Kevin — Chief Financial Officer | 2 | — | — | 6 |
| FOSTER STEVEN M — CEO and President, Director | 1 | — | — | 3 |
| GINN RICHARD — Chief Technology Officer, Director | 1 | — | — | 3 |
| Ferrari Richard — Director | 1 | — | — | 2 |
| HOWARD IVAN — Director | 1 | — | — | 2 |
| Hochschuler Stephen — Director | 1 | — | — | 2 |
| Jacques Kristine M — Director | 1 | — | — | 2 |
| WEIGLE ROBERT K — Director | 1 | — | — | 2 |
Recent Form 4 filings — Tenon Medical, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-11 | 4 | HRT FINANCIAL LP — 10% owner | Purchase (P): 707 @ $3.34 · Sale (S): 50,395 @ $2.61 · Purchase (P): 39,508 @ $3.40 · Sale (S): 9,948 @ $4.27 · Purchase (P): 31,227 @ $2.92 · Purchase (P): 28,267 @ $4.02 · +2 more | EDGAR |
| 2026-09-10 | 4 | Williamson Kevin — Chief Financial Officer | Option exercise (M): 30 @ $0 · Tax withholding (F): 11 @ $3.45 · Option exercise (M): 30 (derivative) @ $0 | EDGAR |
| 2026-09-08 | 4 | HRT FINANCIAL LP — 10% owner | Purchase (P): 1,658 @ $3.98 · Sale (S): 1,506 @ $3.70 | EDGAR |
| 2026-09-03 | 4 | HRT FINANCIAL LP — 10% owner | Purchase (P): 1,790 @ $4.57 · Sale (S): 450 @ $4.53 | EDGAR |
| 2026-09-01 | 4 | HRT FINANCIAL LP — 10% owner | Purchase (P): 12,376 @ $5.21 · Purchase (P): 5,981 @ $6.35 · Sale (S): 4,932 @ $7.07 · Sale (S): 2,091 @ $7.90 · Sale (S): 1,276 @ $4.66 | EDGAR |
| 2026-08-31 | 4 | HRT FINANCIAL LP — 10% owner | Sale (S): 419 @ $4.96 | EDGAR |
| 2026-08-04 | 4 | Ferrari Richard — Director | Option exercise (M): 64,479 @ $0 · Option exercise (M): 64,479 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | Hochschuler Stephen — Director | Option exercise (M): 10,732 @ $0 · Option exercise (M): 10,732 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | HOWARD IVAN — Director | Option exercise (M): 10,732 @ $0 · Option exercise (M): 10,732 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | Jacques Kristine M — Director | Option exercise (M): 10,147 @ $0 · Option exercise (M): 10,147 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | WEIGLE ROBERT K — Director | Option exercise (M): 10,732 @ $0 · Option exercise (M): 10,732 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | FOSTER STEVEN M — CEO and President, Director | Option exercise (M): 140,936 @ $0 · Tax withholding (F): 41,788 @ $0.20 · Option exercise (M): 140,936 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | GINN RICHARD — Chief Technology Officer, Director | Option exercise (M): 126,577 @ $0 · Tax withholding (F): 44,809 @ $0.20 · Option exercise (M): 126,577 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | Williamson Kevin — Chief Financial Officer | Option exercise (M): 58,987 @ $0 · Tax withholding (F): 12,978 @ $0.20 · Option exercise (M): 58,987 (derivative) @ $0 | EDGAR |
| 2026-05-05 | 4 | Geist Wyatt D. — Chief Innovation Officer | Grant/award (A): 136,401 @ $0 | EDGAR |
| 2026-05-05 | 4 | Grawey Nathaniel A. — Chief Commercial Officer | Grant/award (A): 68,201 @ $0 | EDGAR |
| 2026-03-05 | 4 | Williamson Kevin — Chief Financial Officer | Option exercise (M): 1,041 @ $0 · Option exercise (M): 1,041 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | WEIGLE ROBERT K — Director | Option exercise (M): 10,732 @ $0 · Tax withholding (F): 3,413 @ $0.93 · Option exercise (M): 10,732 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | FOSTER STEVEN M — CEO and President, Director | Option exercise (M): 140,936 @ $0 · Option exercise (M): 140,936 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | GINN RICHARD — Chief Technology Officer, Director | Option exercise (M): 126,577 @ $0 · Tax withholding (F): 47,426 @ $0.93 · Option exercise (M): 126,577 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Jacques Kristine M — Director | Option exercise (M): 10,146 @ $0 · Option exercise (M): 583 @ $0 · Option exercise (M): 10,146 (derivative) @ $0 · Option exercise (M): 583 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Williamson Kevin — Chief Financial Officer, Director | Option exercise (M): 58,987 @ $0 · Tax withholding (F): 18,518 @ $0.93 · Option exercise (M): 58,987 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | HOWARD IVAN — Director | Option exercise (M): 10,732 @ $0 · Tax withholding (F): 3,327 @ $0.93 · Option exercise (M): 10,732 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Hochschuler Stephen — Director | Option exercise (M): 10,732 @ $0 · Tax withholding (F): 3,327 @ $0.93 · Option exercise (M): 10,732 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Ferrari Richard — Director | Option exercise (M): 64,478 @ $0 · Option exercise (M): 64,479 (derivative) @ $0 | EDGAR |
| 2025-12-29 | 4 | WEIGLE ROBERT K — Director | Option exercise (M): 78 @ $0 · Option exercise (M): 78 @ $0 · Option exercise (M): 78 (derivative) @ $0 · Option exercise (M): 78 (derivative) @ $0 | EDGAR |
| 2025-12-29 | 4 | HOWARD IVAN — Director | Option exercise (M): 78 @ $0 · Option exercise (M): 78 @ $0 · Option exercise (M): 78 (derivative) @ $0 · Option exercise (M): 78 (derivative) @ $0 | EDGAR |
| 2025-12-22 | 4 | Jacques Kristine M — Director | Grant/award (A): 1,750 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Williamson Kevin — Chief Financial Officer, Director | Option exercise (M): 2,083 @ $0 · Grant/award (A): 6,250 (derivative) @ $0 · Option exercise (M): 2,083 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | FOSTER STEVEN M — CEO and President, Director | Purchase (P): 19,455 · Purchase (P): 19,455 (derivative) | EDGAR |
| 2025-11-18 | 4 | Geist Wyatt D. — Chief Innovation Officer | Purchase (P): 19,455 · Purchase (P): 19,455 (derivative) | EDGAR |
| 2025-11-18 | 4 | Grawey Nathaniel A. — Chief Commercial Officer | Purchase (P): 101,167 · Purchase (P): 101,167 (derivative) | EDGAR |
| 2025-10-15 | 4 | FOSTER STEVEN M — CEO and President, Director | Grant/award (A): 281,872 (derivative) @ $0 | EDGAR |
| 2025-10-15 | 4 | WEIGLE ROBERT K — Director | Grant/award (A): 21,464 (derivative) @ $0 | EDGAR |
| 2025-10-15 | 4 | GINN RICHARD — Chief Technology Officer, Director | Grant/award (A): 253,153 (derivative) @ $0 | EDGAR |
| 2025-10-15 | 4 | Jacques Kristine M — Director | Grant/award (A): 20,293 (derivative) @ $0 | EDGAR |
| 2025-10-15 | 4 | Williamson Kevin — Chief Financial Officer, Director | Grant/award (A): 117,974 (derivative) @ $0 | EDGAR |
| 2025-10-15 | 4 | HOWARD IVAN — Director | Grant/award (A): 21,464 (derivative) @ $0 | EDGAR |
| 2025-10-15 | 4 | Hochschuler Stephen — Director | Grant/award (A): 21,464 (derivative) @ $0 | EDGAR |
| 2025-10-15 | 4 | Ferrari Richard — Director | Grant/award (A): 128,957 (derivative) @ $0 | EDGAR |
Recent 8-K events — Tenon Medical, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-16 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-09 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-31 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-26 | 8-K/A | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-24 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-10 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-24 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-07-20 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-10 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=TNON returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →